ライフサイエンスコーパス: intensive care unit

1 is a reality of the clinical context of the intensive care unit.

2 3 levels within 24 hours of admission to the intensive care unit.

3 Brigham and Women's Hospital Medical Intensive Care Unit.

4 these techniques have not been tested in the intensive care unit.

5 amples collected from trauma patients at the intensive care unit.

6 the operating room, emergency department, or intensive care unit.

7 ill patients from the emergency room to the intensive care unit.

8 which persisted throughout their stay in the intensive care unit.

9 ed in the hospital, of which 88% died in the intensive care unit.

10 7% seldom need pulmonary consultation in the intensive care unit.

11 tric patients from the emergency room to the intensive care unit.

12 noninferiority trial at a tertiary neonatal intensive care unit.

13 ibiotics are used frequently in the neonatal intensive care unit.

14 ients and families at the end-of-life in the intensive care unit.

15 s than or equal to 300 mm Hg admitted to the intensive care unit.

16 ll-cause mortality and length of stay in the intensive care unit.

17 jor cause of infection-related deaths in the intensive care unit.

18 % of patients with sepsis hospitalized in US intensive care units.

19 ered as one of the most critical problems in intensive care units.

20 k place in Geriatric, Emergency and Surgical intensive care units.

21 ritically ill patients in adult and neonatal intensive care units.

22 between 2008 and 2014 in 21 French neonatal intensive care units.

23 ned during routine ROP screening in neonatal intensive care units.

24 prevent bloodstream infections in paediatric intensive care units.

25 hletes and can be twice that for patients in intensive care units.

26 f children admitted to 14 English paediatric intensive care units.

27 ill low and vary considerably among neonatal intensive care units.

28 e the main cause of mortality in non-cardiac intensive care units.

29 cause of morbidity and mortality in neonatal intensive care units.

30 rospective cohort study at tertiary neonatal intensive care units.

31 ions to support surrogate decision-makers in intensive care units.

32 ial performed at 33 US and Canadian neonatal intensive care units.

33 units (15.5%, 95% CI 11.6-20.3) and neonatal intensive care units (10.7%, 9.0-12.7).

34 ence of infections was highest in paediatric intensive care units (15.5%, 95% CI 11.6-20.3) and neona

35 antibiotic selection that was greater in the intensive care unit (77.97% [CI 72.0-83.1] vs 54.73% [CI

36 serin may provide the first ever therapy for intensive care unit acquired weakness in patients.

37 Weakness induced by critical illness (intensive care unit acquired weakness) is a major cause

38 To develop therapy for intensive care unit acquired weakness, it was necessary

39 ower motor neurons as a novel contributor to intensive care unit acquired weakness.

40 Intensive care unit-acquired infections occurred in 13.5

41 th chronic obstructive pulmonary disease and intensive care unit-acquired weakness (ICUAW).

42 visit; and more than one hospitalization or intensive care unit admission < 30 days from death.

43 s 9 days [IQR, 5-16 days]) and lower rate of intensive care unit admission (26% vs 82%), despite a hi

44 supplemental oxygen (P = .001), and require intensive care unit admission (P = .04); however, mechan

45 drome (RR = 6.5, 99% CI: 5.9, 7.1), neonatal intensive care unit admission (RR = 3.4, 99% CI: 3.2, 3.

46 ormation and assessments during the neonatal intensive care unit admission and longitudinal follow-up

47 nificantly lower risk of hospitalization and intensive care unit admission and shorter hospital stays

48 less likely to receive chemotherapy or have intensive care unit admission at the end of life, and we

49 ulting in a lower risk of hospitalization or intensive care unit admission compared with infants born

50 0 days of life, 40.3% of US decedents had an intensive care unit admission compared with less than 18

51 spice use (aRR, 0.86; 95% CI, 0.74 to 0.99), intensive care unit admission or more than one emergency

52 r Hospital Acquired Pressure Injuries during Intensive Care Unit admission than the control group (5

53 yed intubation, (3) Normothermia on Neonatal Intensive Care Unit Admission, (4) Use of a pre-brief, d

54 lism, hysterectomy), complications requiring intensive care unit admission, and maternal death.

55 >/= 1 cm postoperative residual disease, an intensive care unit admission, or a rehospitalization (a

56 disease, defined as mechanical ventilation, intensive care unit admission, or death.

57 Among acutely ill adult patients requiring Intensive Care Unit admission, the provision of optimal

58 rioration and respiratory failure, requiring intensive care unit admission.

59 d more applicable when considering mortality/intensive care unit admission.

60 sepsis developed, which required a prolonged intensive care unit admission.

61 mortality, cardiopulmonary resuscitation, or intensive care unit admission.

62 and respiratory support during the neonatal intensive care unit admission.

63 d that subgroup membership is dynamic during intensive care unit admission.

64 ays (median, 24 days); 14% of cases required intensive care unit admission; 25% reported mechanical v

65 The HSHs were observed to have fewer intensive care unit admissions (1007 [2.6%] vs 1711 [5.0

66 Intensive care unit admissions and grade IV/fatal reacti

67 ncy department visits, hospitalizations, and intensive care unit admissions decreased by 6.0%, 7.9%,

68 However, intensive care unit admissions were more than twice as c

69 ncy department visits, hospitalizations, and intensive care unit admissions).

70 There was no significant difference in Intensive Care Unit admissions, 30 and 90-day mortality,

71 ergency department visits, hospitalizations, intensive care unit admissions, and chemotherapy in the

72 ed serious morbidity, in-hospital mortality, intensive care unit admissions, and cost.

73 Except for one patient who died in the intensive care unit, all patients with cognitive motor d

74 een May 2013 and September 2014 in 20 French intensive care units among 293 patients who had undergon

75 2014, we surveyed all Thai hospitals with an intensive care unit and >/=250 beds.

76 ith various stages of ROP: 3 in the neonatal intensive care unit and 1 in the operating room.

77 rst quantitative data on turn quality in the Intensive Care Unit and highlight the need to reinforce

78 Intensive care unit and hospital discharge rates were 66

79 ductions in procedural inotrope requirement, intensive care unit and hospital length of stay (6.0 ver

80 and 30-day death/stroke, procedural success, intensive care unit and hospital length-of-stay, and rat

81 er among 4 neonates with ROP in the neonatal intensive care unit and in the operating room.

82 bilization of patients in the cardiothoracic intensive care unit and its effect on length of stay has

83 ses are principal caregivers in the neonatal intensive care unit and support mothers to establish and

84 to first physical therapy evaluation in the intensive care unit and the hospital, and mean days of p

85 for admission to a participating paediatric intensive care unit and were expected to need a central

86 ant PDA was conducted at 3 tertiary neonatal intensive care units and affiliated follow-up programs.

87 ation is still a frightening complication in intensive care units and has a high mortality.

88 enic disorders in the neonatal and pediatric intensive care units and its use has a notable effect on

89 The adjusted mean number of hospital, intensive care unit, and emergency room admissions decre

90 risk in patients with liver cirrhosis in the intensive care unit, and fibrinogen and platelet count w

91 anesthesia is widely used in surgery and in intensive care units, and recent evidence indicates that

92 anagement of staphylococcal BSIs in neonatal intensive care units; and (5) defining the impact of VRE

93 nd when <50% of patients received care in an intensive care unit (aOR 3.04, 95% CI 1.49-6.22) but not

94 shock), which are leading causes of death in intensive care units, are still poorly understood.

95 observational study in the level 3 neonatal intensive care unit at Parkland Hospital, Dallas, TX, US

96 s' gestational age; admitted to the neonatal intensive care unit at the Royal Women's Hospital, Melbo

97 e 29, 2011, to October 14, 2014, in neonatal intensive care units at 8 academic institutions, with a

98 y of 350 critically ill patients admitted to intensive care units at an academic medical center to in

99 Medical and Surgical Intensive Care Units at Massachusetts General Hospital (

100 The setting was neonatal intensive care units at The Children's Hospital of Phila

101 ly to receive chemotherapy or be admitted to intensive care units at the end of life.

102 of 441 patients with ARDS admitted to three intensive care units at the University Medical Centre id

103 0-bed, multidisciplinary, tertiary pediatric intensive care unit between January 1, 2009 and August 1

104 otic use in infants admitted to the neonatal intensive care unit between March 1, 2012, and Nov 30, 2

105 nts (<1500 g) admitted to level III neonatal intensive care units between January 1, 2010, and Decemb

106 cutive adult patients admitted to one of two Intensive Care Units between September 2015 to January 2

107 's being discharged alive from the pediatric intensive care unit by a given day, under a range of sta

108 stewardship strategies in a level 3 neonatal intensive care unit by surveillance and assessment of al

109 ment of antibiotic consumption in a neonatal intensive care unit can inform high-yield stewardship ta

110 s (mean [SD] cost, MP $3530 [MP $2410]), and intensive care unit care (mean [SD] cost, MP $7770 [MP $

111 The cardiac intensive care unit (CICU) has changed considerably over

112 Early reports suggest the number of cardiac intensive care unit (CICU) patients with primary noncard

113 fty years after the inception of the cardiac intensive care unit (CICU), noncardiovascular illnesses

114 e respiratory distress syndrome (ARDS) in an intensive care unit cohort of 1,614 subjects.

115 to receive aggressive care and to die in an intensive care unit compared with other residents.

116 Intensive care unit cost per bloodstream infection accou

117 consciousness and cortical responses in the intensive care unit could alter time-sensitive decisions

118 evaluation and treatment in a cardiothoracic intensive care unit could influence length of stay.

119 d discriminative power of our models with an Intensive Care Unit database (MIMIC-III) and demonstrate

120 ors tested were: reason for admission to the intensive care unit, delirium, pain, airway status, hour

121 tional age (SGA) baby; need for the neonatal intensive care unit; doubling of serum creatinine or inc

122 he Palomar Rady Children's Hospital Neonatal Intensive Care Unit during the 35 month study period fro

123 2502 infants were admitted to the neonatal intensive care unit during the two study periods (1607 i

124 cted influenza infection across 38 pediatric intensive care units during November 2008 to April 2016.

125 ake to morbidity through our practice in the intensive care unit each day.

126 f TBI could change current management in the intensive care unit, enabling targeted interventions tha

127 gery, Pediatric Intensive Care, and Neonatal Intensive Care Unit Follow-Up teams to provide a feasibl

128 ctively enrolled 16 patients admitted to the intensive care unit for acute severe traumatic brain inj

129 mechanical ventilation, and admission to the intensive care unit for patients admitted to hospital fo

130 ng 974 adults admitted to a tertiary medical intensive care unit from February 3, 2015 to May 31, 201

131 -center randomized controlled trial at three intensive care units from a French university hospital b

132 onates admitted to 24 participating neonatal intensive care units from four countries (Australia, Can

133 here were 102 (2.9%) patients with unplanned Intensive Care Unit/High Dependency Unit-admissions or u

134 The 3 early treatment groups had similar intensive care unit/hospital stays and high reinterventi

135 ation at the time of listing, whether in the intensive care unit (HR: 2.3; 95% CI: 1.6 to 3.5; p < 0.

136 d to questioning of the beneficial effect of intensive care unit (ICU) admission and to a variable IC

137 g chemotherapy in the final 14 days of life, intensive care unit (ICU) admission in the final 30 days

138 Death, intensive care unit (ICU) admission, and hospital and IC

139 tly increased early postoperative mortality, intensive care unit (ICU) admission, and ICU/hospital le

140 workers or the environment to patients in an intensive care unit (ICU) and a high-dependency unit (HD

141 after day 90, duration of renal support, and intensive care unit (ICU) and hospital length of stay.

142 rly populations; studies based solely in the intensive care unit (ICU) and non-English-language artic

143 the 1.4 million older adults who survive the intensive care unit (ICU) annually in the United States

144 o (range: OR 1.02-1.14), and presence of >20 intensive care unit (ICU) beds (range: OR 1.09-1.62) sig

145 RATIONALE: The austere setting of the intensive care unit (ICU) can suppress expressions of sp

146 eveloping a secondary infection while in the intensive care unit (ICU) display sustained inflammatory

147 r progressive care) is an alternative to the intensive care unit (ICU) for patients with moderate sev

148 y failure episode requiring admission to the intensive care unit (ICU) has been reported in the liter

149 placebo-controlled trial in a general adult intensive care unit (ICU) in Watford General Hospital (W

150 late parenteral nutrition) in the pediatric intensive care unit (ICU) is clinically superior to prov

151 oints measured in terms of duration, such as intensive care unit (ICU) length of stay (LOS), are wide

152 There are limited data on intensive care unit (ICU) management of these patients.

153 Using an experimental rat intensive care unit (ICU) model, not limited by early mo

154 ity of ventilatory support, NIV failure, and intensive care unit (ICU) mortality.

155 S. aureus infection in the intensive care unit (ICU) most commonly manifests as sep

156 Delirium is a common disorder in Intensive Care Unit (ICU) patients and is associated wit

157 Intensive care unit (ICU) patients are particularly at r

158 All non-intensive care unit (ICU) patients at Cleveland Clinic a

159 eaturing routine universal decolonization of intensive care unit (ICU) patients may affect catheter-r

160 n from a prospective study of critically ill intensive care unit (ICU) patients meeting two of four S

161 RATIONALE: Intensive care unit (ICU) patients who receive mechanica

162 rtance: Although frequently used in treating intensive care unit (ICU) patients with sepsis, empirica

163 reactivations of herpesviruses may occur in intensive care unit (ICU) patients, even in those withou

164 Diarrhoea is common in Intensive Care Unit (ICU) patients, with a reported prev

165 httime intensivist staffing with outcomes of intensive care unit (ICU) patients.

166 To determine the discriminative accuracy of intensive care unit (ICU) physicians and nurses in predi

167 cell transplantation (SCT) recipients to the intensive care unit (ICU) remains controversial, especia

168 als involving CAP patients admitted to a non-intensive care unit (ICU) setting from 2007 to 2010, who

169 9 hours; P = 0.002; I(2) = 53%), and reduced intensive care unit (ICU) stay (WMD = -0.23 days; P = 0.

170 to nosocomial infections (NI) and prolonged intensive care unit (ICU) stays.

171 Intensive care unit (ICU) utilization may have important

172 ukemia (AML) commonly require support in the intensive care unit (ICU), but risk factors for admissio

173 r up to 48 hours or until discharge from the intensive care unit (ICU), in addition to standard care.

174 In the intensive care unit (ICU), orotracheal intubation can be

175 RATIONALE: Intensive care unit (ICU)- and mechanical ventilation (M

176 The primary outcome was the number of intensive care unit (ICU)-free days to day 28.

177 transplant recipients from the same thoracic intensive care unit (ICU).

178 e to identify high-risk patients outside the intensive care unit (ICU).

179 equently seen dermatological diseases in the intensive care unit (ICU).

180 fection causes high mortality in patients in intensive care unit (ICU).

181 nt for 1 day before being transferred to the intensive care unit (ICU).

182 close surveillance of these patients in the intensive care unit (ICU).

183 at the level of the population, hospital, or intensive care unit (ICU).

184 thout screening to prevent MRSA infection in intensive-care unit (ICU) patients.

185 CAP outcomes (hospital length of stay [LOS], intensive care unit [ICU] admission, and invasive mechan

186 rtality; secondary: in-hospital mortality or intensive care unit [ICU] length of stay >/=3 days) more

187 9.5 g per deciliter in the operating room or intensive care unit [ICU] or was <8.5 g per deciliter in

188 uma and respiratory failure at 14 university intensive care units (ICUs) across the United States.

189 spective, randomized, open-label trial in 16 intensive care units (ICUs) and 6 countries.

190 , and mortality of sepsis in adult Brazilian intensive care units (ICUs) and association of ICU organ

191 randomized clinical superiority trial in 10 intensive care units (ICUs) at 10 university hospitals i

192 diagnosis in 182 Australian and New Zealand intensive care units (ICUs) from 2000 through 2015.

193 lticenter, randomized trial conducted at 120 intensive care units (ICUs) from 9 countries from Novemb

194 secutive patients admitted for sepsis to two intensive care units (ICUs) in the Netherlands between J

195 Optimal sedation of patients in intensive care units (ICUs) requires the avoidance of pa

196 d with antibiotics, particularly in hospital intensive care units (ICUs).

197 ober 2010 through November 2014 in 4 medical intensive care units (ICUs).

198 nt gram-negative bacteria (MDR-GNB) in adult intensive care units (ICUs).

199 January 2006 and December 2013 from neonatal intensive care units in 25 US children's hospitals inclu

200 Two Intensive Care Units in a large Academic Medical Center

201 birth, were enrolled at 3 level III neonatal intensive care units in Atlanta, Georgia.

202 The study was conducted at 15 intensive care units in Australia and New Zealand from M

203 rt study in pediatric, cardiac, and neonatal intensive care units in eight hospitals, carried out fro

204 linked with structural data from 66 neonatal intensive care units in Germany.

205 l food allergy was conducted in 126 neonatal intensive care units in Japan between April 2010 and Sep

206 l infarction (59% STEMI) admitted to cardiac intensive care units in metropolitan France.

207 : Multicenter randomized clinical trial in 3 intensive care units in Spain (September 2012-October 20

208 atients with sepsis admitted to two tertiary intensive care units in the Netherlands between January

209 ents with severe sepsis or septic shock in 2 intensive care units in the Netherlands from 2011 to 201

210 weight <1500 g) admitted to 1 of 6 neonatal intensive care units in the Netherlands from March 30, 2

211 tamol-induced acute liver failure managed at intensive care units in the UK (London, Birmingham, and

212 sed, placebo-controlled phase 2 trial in two intensive care units in the UK, involving patients fulfi

213 clinical trial conducted in 18 general adult intensive care units in the United Kingdom between Febru

214 winter, 2014, in a convenience sample of 459 intensive-care units in 50 countries across six continen

215 n criteria were admission to a participating intensive-care unit (including transfers) within the enr

216 particularly those requiring admission to an intensive care unit involving respiratory failure, intub

217 lty in older trauma patients admitted to the intensive care unit is often not feasible using traditio

218 l discharge of premature infants in neonatal intensive care units is often delayed due to their inabi

219 A major obstacle to therapy in intensive care units is sepsis caused by severe infectio

220 er, the PDA stent group had a lower adjusted intensive care unit length of stay (5.3 days [95% CI, 4.

221 Duration of mechanical ventilation, intensive care unit length of stay, and in-hospital mort

222 After adjustment for age, intensive care unit level of care, receipt of nephrotoxi

223 al hematoma are key risk factors for needing intensive care unit-level care in children with mTBI and

224 (15.40 versus 7.90 days; P = 0.027), and the intensive care unit LOS (5.55 versus 1.19 days; P = 0.03

225 re likely to experience the MI-EOL care (eg, intensive care unit, mechanical ventilation, odds ratios

226 [3.1%] in the PD group) or length of cardiac intensive care unit (median, 7 [IQR, 6-12] vs 9 [IQR, 5-

227 under intubation/ventilation outside of the intensive care unit (n = 59), or with the patient intuba

228 the patient intubated/ventilated within the intensive care unit (n = 93).Consent to ICOD was obtaine

229 uctured neurobehavioral assessment (Neonatal Intensive Care Unit Network Neurobehavioral Scale) at mu

230 d the least favorable scores on the Neonatal Intensive Care Unit Network Neurobehavioral Scale.

231 primary outcomes were prematurity, neonatal intensive care unit (NICU) admission, congenital malform

232 inal tracts of infants and from the neonatal intensive care unit (NICU) room environment.

233 We analyzed the relation between neonatal intensive care unit (NICU) strategies concerning the rat

234 cesarean delivery, breast-feeding, neonatal intensive care unit [NICU] admission, and absence of pet

235 and most spend their first weeks in neonatal intensive care units (NICUs) [1].

236 cases were reviewed from 2 academic neonatal intensive care units (NICUs) from 2004 to 2015.

237 To determine the proportion of neonatal intensive care units (NICUs) in 2014 that achieved rates

238 rmed skin-breaking procedure in the neonatal intensive care units (NICUs).

239 derive a risk score predicting the need for intensive care unit observation in children with mTBI an

240 found that more than 5 days admitted to the intensive care unit (odds ratio [OR], 4.11; 95% CI, 1.59

241 Blunt trauma patients admitted to the trauma intensive care unit of a level I trauma center were enro

242 patients 65 years and older admitted to the intensive care unit of a single level I trauma center be

243 view was conducted of adults admitted to the intensive care unit of an American College of Surgeons-v

244 36-bed, combined medical/surgical pediatric intensive care unit of an urban, academic, tertiary care

245 abies with type 1 zone 1 ROP at the Neonatal Intensive Care Unit of the Catholic University, Rome, fr

246 tient wards including three male psychiatric intensive care units, one female acute ward and one male

247 (1.3%) patients were either admitted to the intensive care unit or had grade IV/fatal reactions.

248 re time until septic shock, mortality in the intensive care unit or hospital, survival up to 180 days

249 ital cardiac arrest who were hospitalized in intensive care units or general inpatient units were stu

250 2010 and 2011 who were admitted to neonatal intensive care units participating in the Canadian Neona

251 ed miR-542-3p/5p may cause muscle atrophy in intensive care unit patients through the promotion of mi

252 ow/neg) monocytic (M)-MDSCs were expanded in intensive care unit patients with and without sepsis and

253 In a prospective cohort study of intensive care unit patients with respiratory failure an

254 Despite extensive antibiotic treatment of intensive care unit patients, limited data are available

255 ssociated with high mortality, especially in intensive care unit patients.

256 patients, their parents, and the paediatric intensive care unit personnel responsible for their care

257 These professionals are generally intensive care unit physicians with an enhanced focus an

258 discussions regarding extended stays in the intensive care unit, prolonged ventilator management, an

259 for Potentially Inappropriate Treatments in Intensive Care Units) provides examples of potentially i

260 death, the occurrence of adverse events, and intensive care unit resource use.

261 ampsia, gestational age at delivery, days in intensive care unit, sex, age, and body surface area at

262 the causes of potentially avoidable surgical intensive care unit (SICU) admissions and disposition de

263 tiation of CRRT among patients in a surgical intensive care unit (SICU).

264 adverse outcomes in patients in the surgical intensive care unit (SICU).

265 receiving VPT based on severity of illness, intensive care unit status, duration of combination ther

266 The median length of intensive care unit stay (151 vs 117 hours; P < .001), b

267 n time on mechanical ventilation (P = 0.59), intensive care unit stay (P = 0.74), highest primary gra

268 ion (OR, 1.7; 95% CI, 1.05-2.6; P = .03), or intensive care unit stay during index admission (OR, 1.7

269 Median intensive care unit stay was 7 days (interquartile range

270 enal insufficiency were higher, and the mean intensive care unit stay was longer in the LLT group, bu

271 shorter duration of mechanical ventilation, intensive care unit stay, and inotrope use; and fewer el

272 Duration of ventilation, intensive care unit stay, and mortality (6, 17, and 29%

273 load, duration of mechanical ventilation and intensive care unit stay, electrolyte abnormalities and

274 rt-term (duration of mechanical ventilation, intensive care unit stay, hospital stay, and highest pri

275 with duration of mechanical ventilation and intensive care unit stay.

276 atrial fibrillation, bleeding, and length of intensive care unit stay.

277 d increased nosocomial infections, prolonged intensive care unit stays, and poor functional status at

278 children with this SNP had longer pediatric intensive care unit stays, we speculate that this SNP re

279 es, indicated by longer overall hospital and intensive care unit stays.

280 previously demonstrated in numerous surgical intensive care unit studies was not observed, which unde

281 udy involving patients admitted to pediatric intensive care units to define the incremental risk of d

282 re admitted, and 424 cardiac arrests, 13,188 intensive care unit transfers, and 2,840 deaths occurred

283 Organ Failure Assessment (SOFA) score in the intensive care unit up to day 28 (scores for each of fiv

284 ical therapy evaluation and treatment in the intensive care unit using a retrospective chart review.

285 Admission to the intensive care unit was required for 9 patients positive

286 Mortality and care in the intensive care unit were not associated with positive FU

287 Intensive care units were randomized to a quality improv

288 anical ventilation and length of stay in the intensive-care unit were significantly shorter in patien

289 ain injury (TBI) is currently managed in the intensive care unit with a combined medical-surgical app

290 lysed 170 patients consecutively admitted to intensive care unit with diagnosis of culture negative n

291 All patients admitted to the pediatric intensive care unit with length of stay of 4 hours or mo

292 tinely placed extraventricular drain, in the intensive care unit with stable, non-traumatic intracere

293 f consecutive adult patients hospitalized in intensive care units with alteration of consciousness wh

294 Neonatal intensive care units with better work environments, bett

295 ive Pediatric Critical Care Research Network intensive care units with chest compressions for >/=1 mi

296 tioner for surrogates of patients in medical intensive care units with chronic critical illness (i.e.

297 RATIONALE: Patients admitted to intensive care units with sepsis are prone to developing

298 cohort of 265 adult patients admitted to UK intensive care units with sepsis due to community-acquir

299 ients receiving mechanical ventilation in 36 intensive care units, with daily collection of ventilati

300 umannii is a pathogen of major importance in intensive care units worldwide, with the potential to ca